nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivaroxaban—CYP3A5—Cimetidine—obesity	0.108	0.212	CbGbCtD
Rivaroxaban—CYP3A4—Sibutramine—obesity	0.0891	0.175	CbGbCtD
Rivaroxaban—ABCB1—Cimetidine—obesity	0.0704	0.138	CbGbCtD
Rivaroxaban—CYP3A4—Benzphetamine—obesity	0.0675	0.133	CbGbCtD
Rivaroxaban—CYP3A4—Bupropion—obesity	0.0574	0.113	CbGbCtD
Rivaroxaban—CYP3A4—Orlistat—obesity	0.0468	0.092	CbGbCtD
Rivaroxaban—CYP3A4—Cimetidine—obesity	0.0422	0.0828	CbGbCtD
Rivaroxaban—CYP3A4—Topiramate—obesity	0.0276	0.0542	CbGbCtD
Rivaroxaban—F10—cardiovascular system—obesity	0.0027	0.0985	CbGeAlD
Rivaroxaban—F10—adipose tissue—obesity	0.00238	0.0869	CbGeAlD
Rivaroxaban—CYP2J2—cardiovascular system—obesity	0.00221	0.0807	CbGeAlD
Rivaroxaban—F10—adrenal gland—obesity	0.00214	0.0779	CbGeAlD
Rivaroxaban—CYP2J2—pituitary gland—obesity	0.00196	0.0715	CbGeAlD
Rivaroxaban—F10—endocrine gland—obesity	0.00185	0.0676	CbGeAlD
Rivaroxaban—F10—liver—obesity	0.00167	0.0609	CbGeAlD
Rivaroxaban—CYP2J2—endocrine gland—obesity	0.00152	0.0554	CbGeAlD
Rivaroxaban—CYP2J2—liver—obesity	0.00137	0.0499	CbGeAlD
Rivaroxaban—CYP3A5—islet of Langerhans—obesity	0.00108	0.0393	CbGeAlD
Rivaroxaban—CYP3A5—respiratory system—obesity	0.00102	0.0371	CbGeAlD
Rivaroxaban—Asthenia—Phentermine—obesity	0.000898	0.00329	CcSEcCtD
Rivaroxaban—Feeling abnormal—Diethylpropion—obesity	0.000897	0.00329	CcSEcCtD
Rivaroxaban—Infestation NOS—Orlistat—obesity	0.000897	0.00328	CcSEcCtD
Rivaroxaban—Infestation—Orlistat—obesity	0.000897	0.00328	CcSEcCtD
Rivaroxaban—Abdominal pain upper—Bupropion—obesity	0.000897	0.00328	CcSEcCtD
Rivaroxaban—Fatigue—Cimetidine—obesity	0.000893	0.00327	CcSEcCtD
Rivaroxaban—Constipation—Cimetidine—obesity	0.000886	0.00324	CcSEcCtD
Rivaroxaban—Renal failure—Orlistat—obesity	0.000882	0.00323	CcSEcCtD
Rivaroxaban—Urinary tract infection—Orlistat—obesity	0.000872	0.00319	CcSEcCtD
Rivaroxaban—Urticaria—Diethylpropion—obesity	0.000865	0.00317	CcSEcCtD
Rivaroxaban—Dizziness—Phenylpropanolamine—obesity	0.000865	0.00317	CcSEcCtD
Rivaroxaban—Diarrhoea—Phentermine—obesity	0.000857	0.00314	CcSEcCtD
Rivaroxaban—Feeling abnormal—Cimetidine—obesity	0.000854	0.00313	CcSEcCtD
Rivaroxaban—Renal failure—Sibutramine—obesity	0.000853	0.00312	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Orlistat—obesity	0.000848	0.00311	CcSEcCtD
Rivaroxaban—Urinary tract infection—Sibutramine—obesity	0.000844	0.00309	CcSEcCtD
Rivaroxaban—Sinusitis—Orlistat—obesity	0.000842	0.00308	CcSEcCtD
Rivaroxaban—Vomiting—Phenylpropanolamine—obesity	0.000832	0.00305	CcSEcCtD
Rivaroxaban—Dizziness—Phentermine—obesity	0.000828	0.00303	CcSEcCtD
Rivaroxaban—Haematuria—Sibutramine—obesity	0.000828	0.00303	CcSEcCtD
Rivaroxaban—Rash—Phenylpropanolamine—obesity	0.000825	0.00302	CcSEcCtD
Rivaroxaban—Dermatitis—Phenylpropanolamine—obesity	0.000824	0.00302	CcSEcCtD
Rivaroxaban—Epistaxis—Sibutramine—obesity	0.000819	0.003	CcSEcCtD
Rivaroxaban—Sinusitis—Sibutramine—obesity	0.000814	0.00298	CcSEcCtD
Rivaroxaban—Haemoglobin—Orlistat—obesity	0.000809	0.00296	CcSEcCtD
Rivaroxaban—Hepatitis—Orlistat—obesity	0.000805	0.00295	CcSEcCtD
Rivaroxaban—Haemorrhage—Orlistat—obesity	0.000805	0.00295	CcSEcCtD
Rivaroxaban—Vomiting—Phentermine—obesity	0.000796	0.00291	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Orlistat—obesity	0.000795	0.00291	CcSEcCtD
Rivaroxaban—Urethral disorder—Orlistat—obesity	0.000789	0.00289	CcSEcCtD
Rivaroxaban—Rash—Phentermine—obesity	0.000789	0.00289	CcSEcCtD
Rivaroxaban—Dermatitis—Phentermine—obesity	0.000789	0.00289	CcSEcCtD
Rivaroxaban—Headache—Phentermine—obesity	0.000784	0.00287	CcSEcCtD
Rivaroxaban—Haemoglobin—Sibutramine—obesity	0.000783	0.00287	CcSEcCtD
Rivaroxaban—Haemorrhage—Sibutramine—obesity	0.000779	0.00285	CcSEcCtD
Rivaroxaban—Nausea—Phenylpropanolamine—obesity	0.000777	0.00285	CcSEcCtD
Rivaroxaban—Hypersensitivity—Cimetidine—obesity	0.000763	0.0028	CcSEcCtD
Rivaroxaban—Infestation—Bupropion—obesity	0.000757	0.00277	CcSEcCtD
Rivaroxaban—Infestation NOS—Bupropion—obesity	0.000757	0.00277	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Bupropion—obesity	0.00075	0.00275	CcSEcCtD
Rivaroxaban—Diarrhoea—Diethylpropion—obesity	0.000745	0.00273	CcSEcCtD
Rivaroxaban—Nausea—Phentermine—obesity	0.000744	0.00272	CcSEcCtD
Rivaroxaban—Asthenia—Cimetidine—obesity	0.000744	0.00272	CcSEcCtD
Rivaroxaban—Jaundice—Bupropion—obesity	0.000738	0.0027	CcSEcCtD
Rivaroxaban—Urinary tract infection—Bupropion—obesity	0.000736	0.00269	CcSEcCtD
Rivaroxaban—Eye disorder—Sibutramine—obesity	0.000728	0.00267	CcSEcCtD
Rivaroxaban—Immune system disorder—Orlistat—obesity	0.000727	0.00266	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Orlistat—obesity	0.000726	0.00266	CcSEcCtD
Rivaroxaban—Dizziness—Diethylpropion—obesity	0.00072	0.00264	CcSEcCtD
Rivaroxaban—Epistaxis—Bupropion—obesity	0.000714	0.00261	CcSEcCtD
Rivaroxaban—Sinusitis—Bupropion—obesity	0.00071	0.0026	CcSEcCtD
Rivaroxaban—Diarrhoea—Cimetidine—obesity	0.000709	0.0026	CcSEcCtD
Rivaroxaban—Angiopathy—Sibutramine—obesity	0.000707	0.00259	CcSEcCtD
Rivaroxaban—Immune system disorder—Sibutramine—obesity	0.000704	0.00258	CcSEcCtD
Rivaroxaban—Vomiting—Diethylpropion—obesity	0.000692	0.00254	CcSEcCtD
Rivaroxaban—CYP3A5—adipose tissue—obesity	0.000687	0.0251	CbGeAlD
Rivaroxaban—Rash—Diethylpropion—obesity	0.000687	0.00251	CcSEcCtD
Rivaroxaban—Dermatitis—Diethylpropion—obesity	0.000686	0.00251	CcSEcCtD
Rivaroxaban—Dizziness—Cimetidine—obesity	0.000685	0.00251	CcSEcCtD
Rivaroxaban—Haemoglobin—Bupropion—obesity	0.000683	0.0025	CcSEcCtD
Rivaroxaban—Headache—Diethylpropion—obesity	0.000682	0.0025	CcSEcCtD
Rivaroxaban—Hepatitis—Bupropion—obesity	0.000679	0.00249	CcSEcCtD
Rivaroxaban—Haemorrhage—Bupropion—obesity	0.000679	0.00249	CcSEcCtD
Rivaroxaban—Back pain—Orlistat—obesity	0.000678	0.00248	CcSEcCtD
Rivaroxaban—Muscle spasms—Orlistat—obesity	0.000674	0.00247	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Bupropion—obesity	0.000671	0.00246	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Bupropion—obesity	0.000668	0.00244	CcSEcCtD
Rivaroxaban—Urethral disorder—Bupropion—obesity	0.000666	0.00244	CcSEcCtD
Rivaroxaban—Vomiting—Cimetidine—obesity	0.000659	0.00241	CcSEcCtD
Rivaroxaban—Back pain—Sibutramine—obesity	0.000656	0.0024	CcSEcCtD
Rivaroxaban—Rash—Cimetidine—obesity	0.000653	0.00239	CcSEcCtD
Rivaroxaban—Dermatitis—Cimetidine—obesity	0.000653	0.00239	CcSEcCtD
Rivaroxaban—Muscle spasms—Sibutramine—obesity	0.000652	0.00239	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Orlistat—obesity	0.00065	0.00238	CcSEcCtD
Rivaroxaban—Headache—Cimetidine—obesity	0.000649	0.00238	CcSEcCtD
Rivaroxaban—Nausea—Diethylpropion—obesity	0.000647	0.00237	CcSEcCtD
Rivaroxaban—CYP3A5—digestive system—obesity	0.000647	0.0236	CbGeAlD
Rivaroxaban—Erythema multiforme—Bupropion—obesity	0.000642	0.00235	CcSEcCtD
Rivaroxaban—Angioedema—Orlistat—obesity	0.000641	0.00235	CcSEcCtD
Rivaroxaban—Eye disorder—Bupropion—obesity	0.000635	0.00233	CcSEcCtD
Rivaroxaban—Malaise—Orlistat—obesity	0.000632	0.00231	CcSEcCtD
Rivaroxaban—Cardiac disorder—Bupropion—obesity	0.000631	0.00231	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Sibutramine—obesity	0.000629	0.0023	CcSEcCtD
Rivaroxaban—Anaemia—Sibutramine—obesity	0.000627	0.0023	CcSEcCtD
Rivaroxaban—Pain in extremity—Topiramate—obesity	0.000626	0.00229	CcSEcCtD
Rivaroxaban—Osteoarthritis—Topiramate—obesity	0.000626	0.00229	CcSEcCtD
Rivaroxaban—Angioedema—Sibutramine—obesity	0.00062	0.00227	CcSEcCtD
Rivaroxaban—Angiopathy—Bupropion—obesity	0.000616	0.00226	CcSEcCtD
Rivaroxaban—Nausea—Cimetidine—obesity	0.000616	0.00225	CcSEcCtD
Rivaroxaban—Immune system disorder—Bupropion—obesity	0.000614	0.00225	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Bupropion—obesity	0.000612	0.00224	CcSEcCtD
Rivaroxaban—Malaise—Sibutramine—obesity	0.000612	0.00224	CcSEcCtD
Rivaroxaban—Syncope—Sibutramine—obesity	0.000608	0.00223	CcSEcCtD
Rivaroxaban—Chest pain—Orlistat—obesity	0.000597	0.00219	CcSEcCtD
Rivaroxaban—Loss of consciousness—Sibutramine—obesity	0.000596	0.00218	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000593	0.00217	CcSEcCtD
Rivaroxaban—Discomfort—Orlistat—obesity	0.00059	0.00216	CcSEcCtD
Rivaroxaban—Blood creatinine increased—Topiramate—obesity	0.000586	0.00215	CcSEcCtD
Rivaroxaban—Dry mouth—Orlistat—obesity	0.000584	0.00214	CcSEcCtD
Rivaroxaban—Chest pain—Sibutramine—obesity	0.000578	0.00211	CcSEcCtD
Rivaroxaban—ABCB1—islet of Langerhans—obesity	0.000572	0.0209	CbGeAlD
Rivaroxaban—Anaphylactic shock—Orlistat—obesity	0.000572	0.00209	CcSEcCtD
Rivaroxaban—Oedema—Orlistat—obesity	0.000572	0.00209	CcSEcCtD
Rivaroxaban—Back pain—Bupropion—obesity	0.000572	0.00209	CcSEcCtD
Rivaroxaban—Abdominal pain upper—Topiramate—obesity	0.000571	0.00209	CcSEcCtD
Rivaroxaban—Discomfort—Sibutramine—obesity	0.000571	0.00209	CcSEcCtD
Rivaroxaban—Muscle spasms—Bupropion—obesity	0.000569	0.00208	CcSEcCtD
Rivaroxaban—Infection—Orlistat—obesity	0.000568	0.00208	CcSEcCtD
Rivaroxaban—Dry mouth—Sibutramine—obesity	0.000565	0.00207	CcSEcCtD
Rivaroxaban—Nervous system disorder—Orlistat—obesity	0.000561	0.00205	CcSEcCtD
Rivaroxaban—Skin disorder—Orlistat—obesity	0.000556	0.00203	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Sibutramine—obesity	0.000554	0.00203	CcSEcCtD
Rivaroxaban—Oedema—Sibutramine—obesity	0.000554	0.00203	CcSEcCtD
Rivaroxaban—Infection—Sibutramine—obesity	0.00055	0.00201	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Bupropion—obesity	0.000549	0.00201	CcSEcCtD
Rivaroxaban—Anaemia—Bupropion—obesity	0.000547	0.002	CcSEcCtD
Rivaroxaban—Shock—Sibutramine—obesity	0.000545	0.00199	CcSEcCtD
Rivaroxaban—Angioedema—Bupropion—obesity	0.00054	0.00198	CcSEcCtD
Rivaroxaban—Tachycardia—Sibutramine—obesity	0.00054	0.00198	CcSEcCtD
Rivaroxaban—ABCB1—respiratory system—obesity	0.00054	0.0197	CbGeAlD
Rivaroxaban—Skin disorder—Sibutramine—obesity	0.000538	0.00197	CcSEcCtD
Rivaroxaban—CYP3A5—endocrine gland—obesity	0.000534	0.0195	CbGeAlD
Rivaroxaban—Malaise—Bupropion—obesity	0.000533	0.00195	CcSEcCtD
Rivaroxaban—Syncope—Bupropion—obesity	0.00053	0.00194	CcSEcCtD
Rivaroxaban—Angina pectoris—Topiramate—obesity	0.000527	0.00193	CcSEcCtD
Rivaroxaban—Loss of consciousness—Bupropion—obesity	0.00052	0.0019	CcSEcCtD
Rivaroxaban—Hypotension—Sibutramine—obesity	0.000517	0.00189	CcSEcCtD
Rivaroxaban—Dyspepsia—Orlistat—obesity	0.000504	0.00184	CcSEcCtD
Rivaroxaban—Chest pain—Bupropion—obesity	0.000504	0.00184	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.0005	0.00183	CcSEcCtD
Rivaroxaban—Discomfort—Bupropion—obesity	0.000497	0.00182	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Orlistat—obesity	0.000494	0.00181	CcSEcCtD
Rivaroxaban—Dyspnoea—Sibutramine—obesity	0.000494	0.00181	CcSEcCtD
Rivaroxaban—Fatigue—Orlistat—obesity	0.000493	0.00181	CcSEcCtD
Rivaroxaban—Dry mouth—Bupropion—obesity	0.000492	0.0018	CcSEcCtD
Rivaroxaban—Pain—Orlistat—obesity	0.000489	0.00179	CcSEcCtD
Rivaroxaban—Dyspepsia—Sibutramine—obesity	0.000487	0.00178	CcSEcCtD
Rivaroxaban—CYP3A4—digestive system—obesity	0.000485	0.0177	CbGeAlD
Rivaroxaban—Oedema—Bupropion—obesity	0.000483	0.00177	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Bupropion—obesity	0.000483	0.00177	CcSEcCtD
Rivaroxaban—Infestation NOS—Topiramate—obesity	0.000482	0.00177	CcSEcCtD
Rivaroxaban—Infestation—Topiramate—obesity	0.000482	0.00177	CcSEcCtD
Rivaroxaban—CYP3A5—liver—obesity	0.000482	0.0176	CbGeAlD
Rivaroxaban—Infection—Bupropion—obesity	0.00048	0.00176	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Topiramate—obesity	0.000478	0.00175	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Sibutramine—obesity	0.000478	0.00175	CcSEcCtD
Rivaroxaban—Shock—Bupropion—obesity	0.000475	0.00174	CcSEcCtD
Rivaroxaban—Renal failure—Topiramate—obesity	0.000474	0.00174	CcSEcCtD
Rivaroxaban—Constipation—Sibutramine—obesity	0.000473	0.00173	CcSEcCtD
Rivaroxaban—Pain—Sibutramine—obesity	0.000473	0.00173	CcSEcCtD
Rivaroxaban—Nervous system disorder—Bupropion—obesity	0.000473	0.00173	CcSEcCtD
Rivaroxaban—Feeling abnormal—Orlistat—obesity	0.000471	0.00173	CcSEcCtD
Rivaroxaban—Tachycardia—Bupropion—obesity	0.000471	0.00173	CcSEcCtD
Rivaroxaban—Skin disorder—Bupropion—obesity	0.000469	0.00172	CcSEcCtD
Rivaroxaban—Urinary tract infection—Topiramate—obesity	0.000469	0.00172	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Orlistat—obesity	0.000468	0.00171	CcSEcCtD
Rivaroxaban—Haematuria—Topiramate—obesity	0.00046	0.00168	CcSEcCtD
Rivaroxaban—Feeling abnormal—Sibutramine—obesity	0.000456	0.00167	CcSEcCtD
Rivaroxaban—Epistaxis—Topiramate—obesity	0.000455	0.00167	CcSEcCtD
Rivaroxaban—Urticaria—Orlistat—obesity	0.000455	0.00166	CcSEcCtD
Rivaroxaban—ABCB1—adrenal cortex—obesity	0.000453	0.0165	CbGeAlD
Rivaroxaban—Gastrointestinal pain—Sibutramine—obesity	0.000453	0.00166	CcSEcCtD
Rivaroxaban—Sinusitis—Topiramate—obesity	0.000452	0.00166	CcSEcCtD
Rivaroxaban—Abdominal pain—Orlistat—obesity	0.000452	0.00166	CcSEcCtD
Rivaroxaban—Hypotension—Bupropion—obesity	0.000451	0.00165	CcSEcCtD
Rivaroxaban—Agranulocytosis—Topiramate—obesity	0.00045	0.00165	CcSEcCtD
Rivaroxaban—Urticaria—Sibutramine—obesity	0.00044	0.00161	CcSEcCtD
Rivaroxaban—Abdominal pain—Sibutramine—obesity	0.000438	0.0016	CcSEcCtD
Rivaroxaban—Haemoglobin—Topiramate—obesity	0.000435	0.00159	CcSEcCtD
Rivaroxaban—Haemorrhage—Topiramate—obesity	0.000433	0.00159	CcSEcCtD
Rivaroxaban—Hepatitis—Topiramate—obesity	0.000433	0.00159	CcSEcCtD
Rivaroxaban—Dyspnoea—Bupropion—obesity	0.00043	0.00158	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Topiramate—obesity	0.000427	0.00157	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Topiramate—obesity	0.000425	0.00156	CcSEcCtD
Rivaroxaban—Dyspepsia—Bupropion—obesity	0.000425	0.00156	CcSEcCtD
Rivaroxaban—Urethral disorder—Topiramate—obesity	0.000424	0.00155	CcSEcCtD
Rivaroxaban—Hypersensitivity—Orlistat—obesity	0.000422	0.00154	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Bupropion—obesity	0.000417	0.00153	CcSEcCtD
Rivaroxaban—Fatigue—Bupropion—obesity	0.000416	0.00152	CcSEcCtD
Rivaroxaban—ABCB1—cardiovascular system—obesity	0.000414	0.0151	CbGeAlD
Rivaroxaban—Constipation—Bupropion—obesity	0.000413	0.00151	CcSEcCtD
Rivaroxaban—Pain—Bupropion—obesity	0.000413	0.00151	CcSEcCtD
Rivaroxaban—Asthenia—Orlistat—obesity	0.00041	0.0015	CcSEcCtD
Rivaroxaban—Erythema multiforme—Topiramate—obesity	0.000409	0.0015	CcSEcCtD
Rivaroxaban—Hypersensitivity—Sibutramine—obesity	0.000408	0.00149	CcSEcCtD
Rivaroxaban—Pruritus—Orlistat—obesity	0.000405	0.00148	CcSEcCtD
Rivaroxaban—Eye disorder—Topiramate—obesity	0.000405	0.00148	CcSEcCtD
Rivaroxaban—Cardiac disorder—Topiramate—obesity	0.000402	0.00147	CcSEcCtD
Rivaroxaban—CYP3A4—endocrine gland—obesity	0.000401	0.0146	CbGeAlD
Rivaroxaban—Feeling abnormal—Bupropion—obesity	0.000398	0.00146	CcSEcCtD
Rivaroxaban—Asthenia—Sibutramine—obesity	0.000397	0.00145	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Bupropion—obesity	0.000395	0.00145	CcSEcCtD
Rivaroxaban—Angiopathy—Topiramate—obesity	0.000393	0.00144	CcSEcCtD
Rivaroxaban—Pruritus—Sibutramine—obesity	0.000392	0.00143	CcSEcCtD
Rivaroxaban—Diarrhoea—Orlistat—obesity	0.000391	0.00143	CcSEcCtD
Rivaroxaban—Immune system disorder—Topiramate—obesity	0.000391	0.00143	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Topiramate—obesity	0.00039	0.00143	CcSEcCtD
Rivaroxaban—Urticaria—Bupropion—obesity	0.000383	0.0014	CcSEcCtD
Rivaroxaban—Abdominal pain—Bupropion—obesity	0.000382	0.0014	CcSEcCtD
Rivaroxaban—Diarrhoea—Sibutramine—obesity	0.000379	0.00139	CcSEcCtD
Rivaroxaban—Dizziness—Orlistat—obesity	0.000378	0.00139	CcSEcCtD
Rivaroxaban—ABCB1—pituitary gland—obesity	0.000366	0.0134	CbGeAlD
Rivaroxaban—Dizziness—Sibutramine—obesity	0.000366	0.00134	CcSEcCtD
Rivaroxaban—ABCB1—adipose tissue—obesity	0.000365	0.0133	CbGeAlD
Rivaroxaban—Back pain—Topiramate—obesity	0.000364	0.00133	CcSEcCtD
Rivaroxaban—Vomiting—Orlistat—obesity	0.000364	0.00133	CcSEcCtD
Rivaroxaban—Muscle spasms—Topiramate—obesity	0.000362	0.00133	CcSEcCtD
Rivaroxaban—CYP3A4—liver—obesity	0.000362	0.0132	CbGeAlD
Rivaroxaban—Rash—Orlistat—obesity	0.000361	0.00132	CcSEcCtD
Rivaroxaban—Dermatitis—Orlistat—obesity	0.00036	0.00132	CcSEcCtD
Rivaroxaban—Headache—Orlistat—obesity	0.000358	0.00131	CcSEcCtD
Rivaroxaban—Hypersensitivity—Bupropion—obesity	0.000356	0.0013	CcSEcCtD
Rivaroxaban—Vomiting—Sibutramine—obesity	0.000352	0.00129	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Topiramate—obesity	0.00035	0.00128	CcSEcCtD
Rivaroxaban—Rash—Sibutramine—obesity	0.000349	0.00128	CcSEcCtD
Rivaroxaban—Dermatitis—Sibutramine—obesity	0.000349	0.00128	CcSEcCtD
Rivaroxaban—Anaemia—Topiramate—obesity	0.000348	0.00128	CcSEcCtD
Rivaroxaban—Headache—Sibutramine—obesity	0.000347	0.00127	CcSEcCtD
Rivaroxaban—Asthenia—Bupropion—obesity	0.000346	0.00127	CcSEcCtD
Rivaroxaban—ABCB1—digestive system—obesity	0.000344	0.0125	CbGeAlD
Rivaroxaban—Pruritus—Bupropion—obesity	0.000342	0.00125	CcSEcCtD
Rivaroxaban—Nausea—Orlistat—obesity	0.00034	0.00124	CcSEcCtD
Rivaroxaban—Malaise—Topiramate—obesity	0.00034	0.00124	CcSEcCtD
Rivaroxaban—Syncope—Topiramate—obesity	0.000338	0.00124	CcSEcCtD
Rivaroxaban—Loss of consciousness—Topiramate—obesity	0.000331	0.00121	CcSEcCtD
Rivaroxaban—Diarrhoea—Bupropion—obesity	0.00033	0.00121	CcSEcCtD
Rivaroxaban—Nausea—Sibutramine—obesity	0.000329	0.0012	CcSEcCtD
Rivaroxaban—ABCB1—adrenal gland—obesity	0.000327	0.0119	CbGeAlD
Rivaroxaban—Chest pain—Topiramate—obesity	0.000321	0.00117	CcSEcCtD
Rivaroxaban—Dizziness—Bupropion—obesity	0.000319	0.00117	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000319	0.00117	CcSEcCtD
Rivaroxaban—Discomfort—Topiramate—obesity	0.000317	0.00116	CcSEcCtD
Rivaroxaban—Dry mouth—Topiramate—obesity	0.000314	0.00115	CcSEcCtD
Rivaroxaban—Oedema—Topiramate—obesity	0.000308	0.00113	CcSEcCtD
Rivaroxaban—Vomiting—Bupropion—obesity	0.000307	0.00112	CcSEcCtD
Rivaroxaban—Infection—Topiramate—obesity	0.000306	0.00112	CcSEcCtD
Rivaroxaban—Rash—Bupropion—obesity	0.000304	0.00111	CcSEcCtD
Rivaroxaban—Dermatitis—Bupropion—obesity	0.000304	0.00111	CcSEcCtD
Rivaroxaban—Shock—Topiramate—obesity	0.000303	0.00111	CcSEcCtD
Rivaroxaban—Headache—Bupropion—obesity	0.000302	0.00111	CcSEcCtD
Rivaroxaban—Nervous system disorder—Topiramate—obesity	0.000302	0.0011	CcSEcCtD
Rivaroxaban—Tachycardia—Topiramate—obesity	0.0003	0.0011	CcSEcCtD
Rivaroxaban—Skin disorder—Topiramate—obesity	0.000299	0.00109	CcSEcCtD
Rivaroxaban—Hypotension—Topiramate—obesity	0.000287	0.00105	CcSEcCtD
Rivaroxaban—Nausea—Bupropion—obesity	0.000287	0.00105	CcSEcCtD
Rivaroxaban—ABCB1—endocrine gland—obesity	0.000284	0.0104	CbGeAlD
Rivaroxaban—Dyspnoea—Topiramate—obesity	0.000274	0.001	CcSEcCtD
Rivaroxaban—Dyspepsia—Topiramate—obesity	0.000271	0.000991	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Topiramate—obesity	0.000266	0.000972	CcSEcCtD
Rivaroxaban—Fatigue—Topiramate—obesity	0.000265	0.000971	CcSEcCtD
Rivaroxaban—Constipation—Topiramate—obesity	0.000263	0.000963	CcSEcCtD
Rivaroxaban—Pain—Topiramate—obesity	0.000263	0.000963	CcSEcCtD
Rivaroxaban—ABCB1—liver—obesity	0.000256	0.00934	CbGeAlD
Rivaroxaban—Feeling abnormal—Topiramate—obesity	0.000253	0.000928	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Topiramate—obesity	0.000251	0.000921	CcSEcCtD
Rivaroxaban—Urticaria—Topiramate—obesity	0.000244	0.000895	CcSEcCtD
Rivaroxaban—Abdominal pain—Topiramate—obesity	0.000243	0.00089	CcSEcCtD
Rivaroxaban—Hypersensitivity—Topiramate—obesity	0.000227	0.00083	CcSEcCtD
Rivaroxaban—Asthenia—Topiramate—obesity	0.000221	0.000808	CcSEcCtD
Rivaroxaban—Pruritus—Topiramate—obesity	0.000218	0.000797	CcSEcCtD
Rivaroxaban—Diarrhoea—Topiramate—obesity	0.00021	0.00077	CcSEcCtD
Rivaroxaban—Dizziness—Topiramate—obesity	0.000203	0.000745	CcSEcCtD
Rivaroxaban—Vomiting—Topiramate—obesity	0.000196	0.000716	CcSEcCtD
Rivaroxaban—Rash—Topiramate—obesity	0.000194	0.00071	CcSEcCtD
Rivaroxaban—Dermatitis—Topiramate—obesity	0.000194	0.000709	CcSEcCtD
Rivaroxaban—Headache—Topiramate—obesity	0.000193	0.000705	CcSEcCtD
Rivaroxaban—Nausea—Topiramate—obesity	0.000183	0.000669	CcSEcCtD
Rivaroxaban—CYP3A5—Metabolism—SULT2A1—obesity	2.76e-05	0.000145	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GLP1R—obesity	2.76e-05	0.000145	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ECHS1—obesity	2.75e-05	0.000145	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—UCP3—obesity	2.75e-05	0.000145	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—UCP2—obesity	2.75e-05	0.000145	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HSD11B1—obesity	2.75e-05	0.000145	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—DPYD—obesity	2.72e-05	0.000143	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ADH1B—obesity	2.71e-05	0.000142	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ACSL1—obesity	2.67e-05	0.00014	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPARGC1B—obesity	2.67e-05	0.00014	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GPAM—obesity	2.67e-05	0.00014	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—GNB3—obesity	2.66e-05	0.00014	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—HMOX1—obesity	2.65e-05	0.000139	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—DGAT2—obesity	2.63e-05	0.000138	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CS—obesity	2.63e-05	0.000138	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CPS1—obesity	2.63e-05	0.000138	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SUCLA2—obesity	2.63e-05	0.000138	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PRKAR2B—obesity	2.62e-05	0.000138	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—DCN—obesity	2.6e-05	0.000137	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—GNAS—obesity	2.59e-05	0.000136	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HADH—obesity	2.59e-05	0.000136	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PCK1—obesity	2.59e-05	0.000136	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—FADS1—obesity	2.59e-05	0.000136	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—obesity	2.54e-05	0.000133	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—APOB—obesity	2.54e-05	0.000133	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—obesity	2.53e-05	0.000133	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CPT1A—obesity	2.53e-05	0.000133	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ACP5—obesity	2.52e-05	0.000132	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—MUT—obesity	2.51e-05	0.000132	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—LIPE—obesity	2.51e-05	0.000132	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NAMPT—obesity	2.48e-05	0.00013	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—LIPC—obesity	2.46e-05	0.000129	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GCK—obesity	2.46e-05	0.000129	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—G6PD—obesity	2.45e-05	0.000129	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—APOC3—obesity	2.45e-05	0.000129	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HK1—obesity	2.42e-05	0.000127	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SREBF2—obesity	2.42e-05	0.000127	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—DGAT1—obesity	2.41e-05	0.000126	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYB5A—obesity	2.41e-05	0.000126	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CETP—obesity	2.38e-05	0.000125	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—obesity	2.37e-05	0.000124	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SDC1—obesity	2.35e-05	0.000123	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—LPA—obesity	2.34e-05	0.000123	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ACLY—obesity	2.32e-05	0.000122	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—AKR1C3—obesity	2.31e-05	0.000121	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—LPIN1—obesity	2.29e-05	0.00012	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SCARB1—obesity	2.28e-05	0.00012	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOA5—obesity	2.24e-05	0.000118	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALOX12—obesity	2.24e-05	0.000118	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ENPP1—obesity	2.24e-05	0.000118	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SREBF1—obesity	2.21e-05	0.000116	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HMGCS1—obesity	2.17e-05	0.000114	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—obesity	2.16e-05	0.000113	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GOT2—obesity	2.15e-05	0.000113	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SLC22A1—obesity	2.14e-05	0.000112	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CLOCK—obesity	2.14e-05	0.000112	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—PPARA—obesity	2.14e-05	0.000112	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ACADM—obesity	2.1e-05	0.000111	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PLIN1—obesity	2.1e-05	0.000111	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PNPLA2—obesity	2.1e-05	0.000111	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ANGPTL4—obesity	2.1e-05	0.000111	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PFKFB3—obesity	2.1e-05	0.000111	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SAT1—obesity	2.1e-05	0.000111	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—FASN—obesity	2.1e-05	0.000111	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—BCHE—obesity	2.1e-05	0.00011	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GLP1R—obesity	2.09e-05	0.00011	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SULT2A1—obesity	2.09e-05	0.00011	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—DPYD—obesity	2.05e-05	0.000108	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ACACB—obesity	2.05e-05	0.000107	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYTB—obesity	2.05e-05	0.000107	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—OXCT1—obesity	2.05e-05	0.000107	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP2E1—obesity	2.02e-05	0.000106	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—APOA1—obesity	2.01e-05	0.000105	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NQO1—obesity	2e-05	0.000105	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PNLIP—obesity	1.99e-05	0.000105	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SRD5A1—obesity	1.99e-05	0.000105	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PRKAR2B—obesity	1.98e-05	0.000104	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—DCN—obesity	1.96e-05	0.000103	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SDC3—obesity	1.95e-05	0.000102	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GCG—obesity	1.92e-05	0.000101	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SLC2A4—obesity	1.92e-05	0.000101	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CPT1A—obesity	1.91e-05	0.0001	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—STS—obesity	1.9e-05	9.99e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HK2—obesity	1.9e-05	9.99e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP26B1—obesity	1.9e-05	9.99e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYCS—obesity	1.89e-05	9.93e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NAMPT—obesity	1.87e-05	9.83e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPARD—obesity	1.86e-05	9.78e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GCK—obesity	1.86e-05	9.77e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—LIPC—obesity	1.86e-05	9.77e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GOT1—obesity	1.86e-05	9.75e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GGT1—obesity	1.86e-05	9.75e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOC3—obesity	1.85e-05	9.71e-05	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PIK3CA—obesity	1.84e-05	9.68e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NCOA1—obesity	1.83e-05	9.6e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SLC27A1—obesity	1.82e-05	9.58e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—STK11—obesity	1.8e-05	9.46e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP19A1—obesity	1.8e-05	9.46e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CETP—obesity	1.79e-05	9.42e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GLUL—obesity	1.79e-05	9.4e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—FABP4—obesity	1.79e-05	9.4e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SDC1—obesity	1.77e-05	9.32e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—obesity	1.76e-05	9.25e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—AKR1C3—obesity	1.75e-05	9.17e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SCARB1—obesity	1.72e-05	9.02e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ECHS1—obesity	1.7e-05	8.91e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HSD11B1—obesity	1.7e-05	8.91e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—UCP2—obesity	1.7e-05	8.91e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—UCP3—obesity	1.7e-05	8.91e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—COMT—obesity	1.68e-05	8.8e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ADH1B—obesity	1.67e-05	8.76e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SREBF1—obesity	1.67e-05	8.76e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GNB3—obesity	1.65e-05	8.67e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PPARGC1A—obesity	1.65e-05	8.67e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HMOX1—obesity	1.64e-05	8.64e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GPAM—obesity	1.64e-05	8.63e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ACSL1—obesity	1.64e-05	8.63e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPARGC1B—obesity	1.64e-05	8.63e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GOT2—obesity	1.62e-05	8.52e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GNAS—obesity	1.61e-05	8.45e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—FADS1—obesity	1.59e-05	8.37e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HADH—obesity	1.59e-05	8.37e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PCK1—obesity	1.59e-05	8.37e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ALB—obesity	1.59e-05	8.35e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—FASN—obesity	1.59e-05	8.34e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—BCHE—obesity	1.58e-05	8.3e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—APOB—obesity	1.57e-05	8.27e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ACP5—obesity	1.55e-05	8.15e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP2E1—obesity	1.53e-05	8.01e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—G6PD—obesity	1.51e-05	7.94e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NQO1—obesity	1.51e-05	7.92e-05	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—AKT1—obesity	1.51e-05	7.91e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—LPL—obesity	1.5e-05	7.9e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SREBF2—obesity	1.49e-05	7.84e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HK1—obesity	1.49e-05	7.84e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GPX1—obesity	1.47e-05	7.71e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GCG—obesity	1.45e-05	7.59e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SLC2A4—obesity	1.45e-05	7.59e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—LPA—obesity	1.44e-05	7.57e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CD36—obesity	1.43e-05	7.5e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYCS—obesity	1.43e-05	7.5e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—LPIN1—obesity	1.41e-05	7.41e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GGT1—obesity	1.4e-05	7.36e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GOT1—obesity	1.4e-05	7.36e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOA5—obesity	1.38e-05	7.26e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NCOA1—obesity	1.38e-05	7.25e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—STK11—obesity	1.36e-05	7.14e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP19A1—obesity	1.36e-05	7.14e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—MTHFR—obesity	1.35e-05	7.11e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PPARA—obesity	1.33e-05	6.98e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CLOCK—obesity	1.32e-05	6.93e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SLC22A1—obesity	1.32e-05	6.93e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—AGT—obesity	1.29e-05	6.76e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SULT2A1—obesity	1.29e-05	6.75e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GLP1R—obesity	1.29e-05	6.75e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—DPYD—obesity	1.26e-05	6.64e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—COMT—obesity	1.26e-05	6.64e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—APOE—obesity	1.26e-05	6.62e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CAV1—obesity	1.25e-05	6.56e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPARGC1A—obesity	1.25e-05	6.55e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GNB3—obesity	1.25e-05	6.55e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—APOA1—obesity	1.25e-05	6.54e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HMOX1—obesity	1.24e-05	6.52e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PRKAR2B—obesity	1.22e-05	6.39e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GNAS—obesity	1.21e-05	6.37e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—DCN—obesity	1.21e-05	6.35e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOB—obesity	1.19e-05	6.24e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CPT1A—obesity	1.18e-05	6.17e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NAMPT—obesity	1.15e-05	6.05e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—LIPC—obesity	1.15e-05	6.02e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GCK—obesity	1.15e-05	6.02e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOC3—obesity	1.14e-05	5.98e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PIK3CG—obesity	1.14e-05	5.97e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—LPL—obesity	1.13e-05	5.96e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GPX1—obesity	1.11e-05	5.81e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CETP—obesity	1.11e-05	5.8e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PPARG—obesity	1.1e-05	5.77e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SDC1—obesity	1.09e-05	5.74e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—POMC—obesity	1.08e-05	5.69e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CD36—obesity	1.08e-05	5.66e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—INS—obesity	1.08e-05	5.66e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—AKR1C3—obesity	1.08e-05	5.65e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SCARB1—obesity	1.06e-05	5.56e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SREBF1—obesity	1.03e-05	5.4e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—MTHFR—obesity	1.02e-05	5.37e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPARA—obesity	1e-05	5.26e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PIK3CD—obesity	1e-05	5.25e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GOT2—obesity	1e-05	5.25e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALB—obesity	9.87e-06	5.18e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—FASN—obesity	9.78e-06	5.14e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—BCHE—obesity	9.74e-06	5.12e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—AGT—obesity	9.71e-06	5.1e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOE—obesity	9.51e-06	5e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PIK3R1—obesity	9.44e-06	4.96e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NOS3—obesity	9.44e-06	4.96e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CAV1—obesity	9.42e-06	4.95e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOA1—obesity	9.4e-06	4.94e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP2E1—obesity	9.4e-06	4.94e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NQO1—obesity	9.29e-06	4.88e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SLC2A4—obesity	8.91e-06	4.68e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GCG—obesity	8.91e-06	4.68e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYCS—obesity	8.79e-06	4.62e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PIK3CB—obesity	8.72e-06	4.58e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PTGS2—obesity	8.64e-06	4.54e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GGT1—obesity	8.63e-06	4.53e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GOT1—obesity	8.63e-06	4.53e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PIK3CG—obesity	8.58e-06	4.51e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NCOA1—obesity	8.5e-06	4.46e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—STK11—obesity	8.38e-06	4.4e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP19A1—obesity	8.38e-06	4.4e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPARG—obesity	8.29e-06	4.35e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—POMC—obesity	8.17e-06	4.29e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—INS—obesity	8.13e-06	4.27e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—COMT—obesity	7.79e-06	4.09e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GNB3—obesity	7.68e-06	4.03e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPARGC1A—obesity	7.68e-06	4.03e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HMOX1—obesity	7.64e-06	4.01e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PIK3CD—obesity	7.55e-06	3.96e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GNAS—obesity	7.48e-06	3.93e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALB—obesity	7.45e-06	3.91e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOB—obesity	7.32e-06	3.85e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PIK3R1—obesity	7.13e-06	3.74e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NOS3—obesity	7.13e-06	3.74e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—LPL—obesity	6.99e-06	3.67e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GPX1—obesity	6.82e-06	3.58e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CD36—obesity	6.64e-06	3.49e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PIK3CB—obesity	6.58e-06	3.45e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PTGS2—obesity	6.52e-06	3.42e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—MTHFR—obesity	6.29e-06	3.31e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPARA—obesity	6.18e-06	3.24e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—AGT—obesity	5.98e-06	3.14e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOE—obesity	5.86e-06	3.08e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CAV1—obesity	5.81e-06	3.05e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOA1—obesity	5.79e-06	3.04e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PIK3CA—obesity	5.31e-06	2.79e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PIK3CG—obesity	5.29e-06	2.78e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPARG—obesity	5.1e-06	2.68e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—POMC—obesity	5.03e-06	2.64e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—INS—obesity	5.01e-06	2.63e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PIK3CD—obesity	4.65e-06	2.44e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALB—obesity	4.59e-06	2.41e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PIK3R1—obesity	4.39e-06	2.31e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NOS3—obesity	4.39e-06	2.31e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—AKT1—obesity	4.34e-06	2.28e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PIK3CB—obesity	4.05e-06	2.13e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PTGS2—obesity	4.02e-06	2.11e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PIK3CA—obesity	4.01e-06	2.11e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—AKT1—obesity	3.28e-06	1.72e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PIK3CA—obesity	2.47e-06	1.3e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—AKT1—obesity	2.02e-06	1.06e-05	CbGpPWpGaD
